Many top healthcare stocks provide investors with long-term stability, promising growth prospects, and in some cases even a dividend.

Yet, investors don't appear to be sold on the fact that Bristol Myers Squibb (NYSE: BMY) checks off all those boxes. The business faces some concerning challenges in the near term, but there is hope that it can get back to growing in the long run.

For contrarian investors willing to take a chance on the healthcare company, there could be some promising upside, especially given its low valuation. Does Bristol Myers Squibb stock have the potential to make you a millionaire?

Continue reading

Source Fool.com